Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$155,180.00
Oct 1, 2013
Device for recanalization of peripheral and coronary arteries
$600,000.00
Oct 1, 2013
Minimally Invasive Curved Intramedullary Fixation (MICIF) for pelvic bone fractures
$160,000.00
Oct 1, 2013
Chimeric Oncolytic Virus for Brain Cancer Treatment
$1,400,000.00
Oct 1, 2013
The Peritoneal Dialysis Outcomes and Practice Patterns Study (P-DOPPS)
$158,430.00
Oct 1, 2013
Integrated Surgical Lighting and Navigation System
$589,200.00
Oct 1, 2013
Intravesical Docetaxel Formulation for the Treatment of Ta/T1 Stage Bladder Cancer
$99,050.00
Oct 1, 2013
At the intersection of clinical ethics and harm reduction: Clinician perspectives on reducing discharges against medical advice for substance using patients living with HIV and Hepatitis C
$1,205,760.00
Oct 1, 2013
Validation of two novel pancreatic cancer biomarkers: CUZD1 and LAMC2
$135,000.00
Oct 1, 2013
Cognitive Insight, Metacognition and Structural Neuroimaging in Youth at Clinical High Risk of Psychosis
$96,821.00
Oct 1, 2013
Bioethics on the Ground: Criminalization and the Changing Landscape of HIV/AIDS Advocacy